 |
|
| fasciolicide-endectocide with residual effect. |
|
|
| formula |
|
|
| indications |
endectocide and fasciolicide with strong residual power, recommended for treatment, control and prophylaxis of internal parasitosis (produced by adult and immature forms of fasciola hepatica and gastrointestinal nematodes) and external parasitosis (lice, mange, flies, oestrosis, larval miasis and tick). the association of ivermectin and closantel has demonstrated compatibility and effect of each component. |
| dosage y administration |
subcutaneous injectable route. General dosage is 1 mL/40 kg of body weight. the administration of the total dose in two different sites is recommended, in order to avoid possible irritations. |
| trade presentation |
plastic vial of 20 mL, plastic vial of 50 mL, plastic vial of 100 mL, plastic vial of 250 mL and plastic vial of 500 mL. |
|